Fungal Nasal Polyposis during COVID-19 Pandemic - A Review of 4 Cases

  • Gayathri Postgraduate Resident, Department of Pathology, Chettinad Hospital & Research Institute, Tamil Nadu, India.
  • Vijayashree Raghavan Professor & HoD, Department of Pathology, Chettinad Hospital & Research Institute, Tamil Nadu, India.
  • Aarthi Kannan MD & Professor, Department of Pathology, Chettinad Hospital & Research Institute, Tamil Nadu, India.
Keywords: COVID-19, Fungal Nasal Polyposis, Aspergillus, Mucormycosis

Abstract

Nasal polyps are usually associated with inflammation, allergy or mucoviscidosis. The global burden of patients with COVID-19 infection, including that in the Indian sub-continent,is still very high and they are at an increased risk of developing invasive fungal infections probably due to their immunocompromised state. Here, we review 4 cases of fungal nasal polyposis in patients with an ongoing or past history of COVID-19 infection with or without associated co-morbidities.

How to cite this article:
Devi G, Raghavan V, Kannan A. Fungal Nasal Polyposis during COVID-19 Pandemic - A Review of 4 Cases. Special Issue - COVID-19 & Other Communicable Disease. 2022;245-252.

DOI: https://doi.org/10.24321/0019.5138.202237

Published
2022-03-16
Issue
2022: Special Issue - COVID-19 & Other Communicable Diseases
Section
Case Report

Copyright (c) 2022 Author's

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.